| ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up F Honecker, J Aparicio, D Berney, J Beyer, C Bokemeyer, R Cathomas, ... Annals of oncology 29 (8), 1658-1686, 2018 | 321 | 2018 |
| Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort G Daugaard, MG Gundgaard, MS Mortensen, M Agerbæk, NV Holm, ... Journal of Clinical Oncology 32 (34), 3817-3823, 2014 | 250 | 2014 |
| A nationwide cohort study of stage I seminoma patients followed on a surveillance program MS Mortensen, J Lauritsen, MG Gundgaard, M Agerbæk, NV Holm, ... European urology 66 (6), 1172-1178, 2014 | 192 | 2014 |
| Second malignant neoplasms and cause of death in patients with germ cell cancer: a Danish nationwide cohort study MG Kier, MK Hansen, J Lauritsen, MS Mortensen, M Bandak, M Agerbaek, ... JAMA oncology 2 (12), 1624-1627, 2016 | 88 | 2016 |
| Cardiovascular risk factors and disease after male germ cell cancer J Lauritsen, MK Hansen, M Bandak, MB Kreiberg, JW Skøtt, T Wagner, ... Journal of Clinical Oncology 38 (6), 584-592, 2020 | 84 | 2020 |
| Prognostic factors and treatment results after bleomycin, etoposide, and cisplatin in germ cell cancer: a population-based study MG Kier, J Lauritsen, MS Mortensen, M Bandak, KK Andersen, ... European Urology 71 (2), 290-298, 2017 | 81 | 2017 |
| Pulmonary function in patients with germ cell cancer treated with bleomycin, etoposide, and cisplatin J Lauritsen, MGG Kier, M Bandak, MS Mortensen, FB Thomsen, ... Journal Of Clinical Oncology 34 (13), 1492-1499, 2016 | 71 | 2016 |
| Testosterone deficiency in testicular cancer survivors–a systematic review and meta‐analysis M Bandak, N Jørgensen, A Juul, IR Vogelius, J Lauritsen, MG Kier, ... Andrology 4 (3), 382-388, 2016 | 68 | 2016 |
| Late adverse effects and quality of life in survivors of testicular germ cell tumour M Chovanec, J Lauritsen, M Bandak, C Oing, GG Kier, M Kreiberg, ... Nature Reviews Urology 18 (4), 227-245, 2021 | 58 | 2021 |
| Late relapses in stage I testicular cancer patients on surveillance MS Mortensen, J Lauritsen, MGG Kier, M Bandak, AL Appelt, M Agerbæk, ... European Urology 70 (2), 365-371, 2016 | 46 | 2016 |
| Surveillance versus adjuvant radiotherapy for patients with high‐risk stage I seminoma MS Mortensen, M Bandak, MGG Kier, J Lauritsen, M Agerbæk, NV Holm, ... Cancer 123 (7), 1212-1218, 2017 | 45 | 2017 |
| Germ cell cancer and multiple relapses: toxicity and survival J Lauritsen, MGG Kier, MS Mortensen, M Bandak, R Gupta, NV Holm, ... Journal of Clinical Oncology 33 (28), 3116-3123, 2015 | 38 | 2015 |
| Longitudinal changes in serum levels of testosterone and luteinizing hormone in testicular cancer patients after orchiectomy alone or bleomycin, etoposide, and cisplatin M Bandak, N Jørgensen, A Juul, J Lauritsen, MGG Kier, MS Mortensen, ... European Urology Focus 4 (4), 591-598, 2018 | 37 | 2018 |
| Renal impairment and late toxicity in germ-cell cancer survivors J Lauritsen, MS Mortensen, MGG Kier, IJ Christensen, M Agerbaek, ... Annals of Oncology 26 (1), 173-178, 2015 | 37 | 2015 |
| Screening for carcinomain situ in the contralateral testicle in patients with testicular cancer: a population-based study MGG Kier, J Lauritsen, K Almstrup, MS Mortensen, BG Toft, ... Annals of Oncology 26 (4), 737-742, 2015 | 36 | 2015 |
| Sexual function in a nationwide cohort of 2,260 survivors of testicular cancer after 17 years of followup M Bandak, J Lauritsen, C Johansen, M Kreiberg, JW Skøtt, M Agerbaek, ... The Journal of urology 200 (4), 794-800, 2018 | 34 | 2018 |
| Preorchiectomy Leydig cell dysfunction in patients with testicular cancer M Bandak, N Jørgensen, A Juul, J Lauritsen, MGG Kier, MS Mortensen, ... Clinical Genitourinary Cancer 15 (1), e37-e43, 2017 | 29 | 2017 |
| Nationwide survival benefit after implementation of first-line immunotherapy for patients with advanced nsclc—Real world efficacy MT Mouritzen, A Carus, M Ladekarl, P Meldgaard, AWM Nielsen, ... Cancers 13 (19), 4846, 2021 | 28 | 2021 |
| Psychological stress in long-term testicular cancer survivors: a Danish nationwide cohort study M Kreiberg, M Bandak, J Lauritsen, KK Andersen, JW Skøtt, C Johansen, ... Journal of Cancer Survivorship 14, 72-79, 2020 | 24 | 2020 |
| Prediction of nephrotoxicity associated with cisplatin-based chemotherapy in testicular cancer patients SL Garcia, J Lauritsen, Z Zhang, M Bandak, MD Dalgaard, RL Nielsen, ... JNCI Cancer Spectrum 4 (3), pkaa032, 2020 | 23 | 2020 |
Gedske DaugaardRigshospitaletVerified email at regionh.dk
